Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

FTNT's Premium Valuation Raises Concerns: Buy, Sell or Hold the Stock?
FTNT's Premium Valuation Raises Concerns: Buy, Sell or Hold the Stock?

Fortinet FTNT has emerged as a formidable player in the cybersecurity landscape, yet its current valuation metrics suggest investors should approach the stock with measured caution. The company's

Royal Gold Hits 52-Week High: What's Driving Its Performance?
Royal Gold Hits 52-Week High: What's Driving Its Performance?

Shares of Royal Gold, Inc. RGLD scaled a new 52-week high of $224.77 on Friday before ending the session lower at $218.75. The increase was fueled by near-record gold prices.

The company currently

Will Rising Capex Pressure Hurt Alibaba's Margin and AI Strategy?
Will Rising Capex Pressure Hurt Alibaba's Margin and AI Strategy?

Alibaba Group Holding's BABA ambitious infrastructure expansion threatens to further erode profitability as the company locks in RMB 380 billion in capital commitments over the next three years for

Final Full Trading Week of 2025 Filled with Data: https://staticx-tuner.zacks.com/images/articles/main/ed/136861.webp
Final Full Trading Week of 2025 Filled with Data

Monday, December 15, 2025Considering we have wound down another quarterly earnings season and are officially into the holidays this year, we do have an eventful market ahead of us. Delayed jobs and

Teck Resources Progresses With Anglo American Merger Deal
Teck Resources Progresses With Anglo American Merger Deal

Teck Resources Limited TECK announced that the Supreme Court of British Columbia approved its previously announced merger agreement with Anglo American plc NGLOY. This pushes the deal closer to

Abbott Gains From Lingo CGM's Expansion on Android Platform
Abbott Gains From Lingo CGM's Expansion on Android Platform

Abbott Laboratories ABT recently announced that Lingo, its first over-the-counter biowearable continuous glucose monitor system (CGM), can now be used with Android devices. Previously available only

Here's Why You Should Add OGE Stock to Your Portfolio Right Now
Here's Why You Should Add OGE Stock to Your Portfolio Right Now

OGE Energy Corp. OGE focuses on consistent investments in infrastructure upgrades to better serve its customers. The company is also steadily expanding its renewable generation assets. Given its

GS Sees M&A Momentum to Continue in 2026: Implications for Its IB Fees
GS Sees M&A Momentum to Continue in 2026: Implications for Its IB Fees

The Goldman Sachs Group’s GS chief financial officer, Denis Coleman, affirmed its strong confidence in global mergers and acquisitions (M&A) at the firm’s 2025 Global Conference held on Dec 9. The

NANO Nuclear Energy to Report Q4 Earnings: How to Play the Stock?
NANO Nuclear Energy to Report Q4 Earnings: How to Play the Stock?

NANO Nuclear Energy Inc. NNE is scheduled to release fiscal fourth-quarter results on Dec. 18, after market close. The Zacks Consensus Estimate is currently pegged at a loss of 33 cents per share

Goldman Stock Trades Near 52-Week High: How to Approach Now?
Goldman Stock Trades Near 52-Week High: How to Approach Now?

The Goldman Sachs Group GS shares have been performing remarkably well of late. At present, the stock is trading near its 52-week high of $919.10 hit during Thursday’s trading session. Over the past

CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval
CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval

Novo Nordisk NVO announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the EU approval of a higher

UNM Stock Trading at a Discount to Industry at 1.2X: Time to Hold?
UNM Stock Trading at a Discount to Industry at 1.2X: Time to Hold?

Unum Group UNM shares are trading at a discount compared to the Zacks Accident and Health Insurance industry. Its forward price-to-book value of 1.2X is lower than the industry average of 1.75X, the

GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU
GSK's Nucala for COPD and Depemokimab for Asthma Get CHMP Nod in EU

GSK plc GSK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion recommending the approval of Nucala as an

Should Investors Buy OKLO Stock After Its Massive 2025 Run?
Should Investors Buy OKLO Stock After Its Massive 2025 Run?

Oklo Inc. OKLO has delivered one of the most eye-catching rallies in the market this year, climbing more than 300% as investors rushed into advanced nuclear names tied to artificial intelligence

BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care
BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care

Baxter International Inc. BAX recently shared real-world data at the American Society of Health-System Pharmacists (“ASHP”) 2025 Midyear Clinical Meeting, highlighting the benefits of integrating

Gencor Stock Gains Post Q4 Earnings on Strong Cash, Revenue Dip
Gencor Stock Gains Post Q4 Earnings on Strong Cash, Revenue Dip

Shares of Gencor Industries, Inc. GENC gained 4.1% since the company reported results for the quarter ended Sept. 30, 2025, against a 0.4% decline in the S&P 500 Index over the same period. Over the

McCormick's Q3 Volumes Gain Traction: What to Expect in 2026?
McCormick's Q3 Volumes Gain Traction: What to Expect in 2026?

McCormick & Company, Inc.’s MKC recent performance highlights continued volume momentum, led by the consumer segment. In the third quarter of fiscal 2025, organic net sales grew 2% year over year

Should Investors Pay a Premium for ExxonMobil Stock Now?
Should Investors Pay a Premium for ExxonMobil Stock Now?

Exxon Mobil Corporation XOM is currently considered expensive on a relative basis, with the stock trading at a 7.71x trailing 12-month Enterprise Value to Earnings Before Interest, Taxes

Can These 3 Semiconductor Stocks Lead the Next Tech Rally in 2026?
Can These 3 Semiconductor Stocks Lead the Next Tech Rally in 2026?

The bull run in equity markets in the outgoing year, following the tariff bloodbath, was largely driven by AI, with investors betting big on its inherent growth prospects. AI-based semiconductor

INOD vs. PLTR: Which AI Data Stock Has More Upside Now?
INOD vs. PLTR: Which AI Data Stock Has More Upside Now?

Artificial intelligence spending is increasingly shifting from experimentation to scaled deployment, forcing enterprises and governments to rethink how they collect, structure, govern and

4 Construction Stocks Gaining Momentum Heading Into 2026
4 Construction Stocks Gaining Momentum Heading Into 2026

U.S. construction activity is entering a more durable expansion phase as federal infrastructure spending, grid modernization, energy transition projects and data-center development converge

NET Gains From Synergy in Its AI and Security Products: What's Next?
NET Gains From Synergy in Its AI and Security Products: What's Next?

Cloudflare NET has structured its product portfolio to increasingly benefit from strong synergy and seamless compatibility across its offerings. Cloudflare now commands more than 55

3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains: https://www.marketbeat.com/logos/articles/med_20251211110905_3-companies-turning-big-cash-flow-into-bigger-shar.png
3 Companies Turning Big Cash Flow Into Bigger Shareholder Gains

Inflation, interest rates, and broader economic uncertainty have forced companies across many sectors to prioritize efficiency. In this environment, it can be particularly challenging for firms to

AMAT Gains From Traction in WFE Products: A Sign of More Upside?
AMAT Gains From Traction in WFE Products: A Sign of More Upside?

Applied Materials’ AMAT latest wafer fabrication equipment (WFE) is experiencing increased demand due to rising usage of semiconductors in artificial intelligence and high performance computing

META Down 19% From 52-Week High: What Awaits the Stock in 2026?
META Down 19% From 52-Week High: What Awaits the Stock in 2026?

Meta Platforms’ META shares closed at $644.23 on Dec. 12, down roughly 19.1% from the 52-week high of $796.25 it hit on Aug. 15. META shares have returned a meager 3.2% in the trailing 12-month